ethacrynic acid has been researched along with Cancer of Kidney in 4 studies
Ethacrynic Acid: A compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic.
etacrynic acid : An aromatic ether that is phenoxyacetic acid in which the phenyl ring is substituted by chlorines at positions 2 and 3, and by a 2-methylidenebutanoyl group at position 4. It is a loop diuretic used to treat high blood pressure resulting from diseases such as congestive heart failure, liver failure, and kidney failure. It is also a glutathione S-transferase (EC 2.5.1.18) inhibitor.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Advanced renal cancer has still a very poor prognosis." | 1.39 | Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide. ( Kim, Y; Koller, CM; Schmidt-Wolf, IG, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koller, CM | 1 |
| Kim, Y | 1 |
| Schmidt-Wolf, IG | 2 |
| Von Schulz-Hausmann, SA | 1 |
| Schmeel, LC | 1 |
| Schmeel, FC | 1 |
| Murphy, GP | 1 |
| Mirand, EA | 1 |
| Johnston, GS | 1 |
| Gibbons, RP | 1 |
| Schirmer, HK | 1 |
| Scott, WW | 1 |
| Tucker, RM | 1 |
| Hunt, JC | 1 |
1 review available for ethacrynic acid and Cancer of Kidney
| Article | Year |
|---|---|
Recent advances in the medical and surgical treatment of hypertension.
Topics: Adrenocortical Hyperfunction; Antihypertensive Agents; Diet, Sodium-Restricted; Diuretics; Ethacryni | 1968 |
3 other studies available for ethacrynic acid and Cancer of Kidney
| Article | Year |
|---|---|
Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Ce | 2013 |
Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
Topics: beta Catenin; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Ciclopirox; Drug Combinations; | 2014 |
Erythropoietin alterations in human genitourinary disease states: correlation with experimental observations.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Animals; Brain Neoplasms; Child; Child, Preschool; Dogs; El | 1968 |